ATS 2024 Final Program

Click on the session title to view the speakers

137

MONDAY • MAY 20

P221 Club Cell Secretory Protein 16 (CC16) Engages the ALX Receptor to Inhibit Pro-inflammatory Cytokine Expression by Human Epithelial Cells P222 Succinate Receptor 1 (SUCNR1) Expression in Airway Epithelial Cells

P601 Adherence and Persistence with Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate Among Patients with Chronic Obstructive Pulmonary Disease: A Real-world United States Study P602 An Investigation on the Effects of Prompt Versus Delayed Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol Single-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in the United States P603 MicroRNA-mediated Downregulation of Jagged1 During HIV Mediated COPD: Implications for Disrupted Notch Signaling in Pulmonary Health P604 Treatment and Disease Burden Among Patients With Moderate or Severe COPD: Real World Study P605 Unveiling the Therapeutic Potential of Mesenchymal Stem Cells in the Pursuit of Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review P606 Sputum and Serum Immunoglobulins in Chronic Obstructive Pulmonary Disease P607 Sputum Transcriptomic Changes Associated With Menthol Tobacco and Nicotine Products P608 The Neutrophil Lymphocyte Ratio as a Predictor of Acute Exacerbations Among Patients With COPD in Uganda P609 To Explore Type 1 Versus Type 2 Inflammation Etiologies With the D-dimer and C-reactive Protein Levels and Analyze Their Relation With the Severity of Chronic Obstructive Pulmonary Disease P610 Investigating Prevalence of Eosinophilia and Inhaled Corticosteroid Use in Puerto Rican Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Analysis P611 Eblasakimab Significantly Alleviates IL-4 and IL-13-induced Bronchial Airway Constriction in COPD-Derived Lung Slices P612 Lung Immunophenotyping Combined With Machine Learning Uncovers Novel Copdendotypes

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B32 BIOMARKERS AND TRANSLATIONAL STUDIES IN COPD AND CHRONIC AIRWAYS DISEASES 9:15 a.m. - 4:15 p.m. San Diego Convention Center Area F (Hall A-B2, Ground Level) Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P593 Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema P594 Distinct Pharmacological Profiles of IL-33 Antibodies P595 Acceleration of Inflammation in Primary Human Bronchial Epithelial Cells and Microrna Mediated Gene Silencing in the Context of HIV and Cigarette Smoke P596 Polygenic and Transcriptional Risk Scores Identify Chronic Obstructive Pulmonary Disease Subtypes P597 Effects of Vaping of Nicotine and THC E-cigarettes on Gene Expression, Airway Resistance, and Saliva and Sputum Production P598 Association of Biomarker Suppression With St George’S Respiratory Questionnaire and COPD Assessment Test in Patients With Alpha-1 Antitrypsin Deficiency Treated With Alvelestat: Results From the Treatment of Alpha-1-antitrypsin Deficiency (Atalanta) Study

P599 Lung Cell-type Specific Interactions With Streptococcus in COPD P600 Allergic Sensitization and IgE Levels in Eosinophilic COPD

ATS 2024 Conference Program • San Diego, CA